JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 23 No. 6 517-524
© 1982 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato-Azuma, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato-Azuma, M.

Tc-99m(Sn)-N-Pyridoxylaminates: A New Series of Hepatobiliary Imaging Agents

Makoto Kato-Azuma

Nihon Medi-Physics Co., Ltd., Takarazuka, Japan

Correspondence: For reprints contact: Makoto Kato-Azuma, Research and Development Section, Technical Department, Nihon Medi-Physics Co., Ltd., 4, 2-1, Takatsukasa, Takarazuka, Hyogo Pref., Japan 665.

ABSTRACT

Three derivatives of N-pyridoxylamino acid were synthesized: Tc-99m(Sn)-N-pyridoxylphenylalanine, -N-pyridoxyltryptophan, and -N-pyridoxyl-5-methyltryptophan. The chemical and biologic properties of each complex was found to be quite analogous to those of the corresponding Tc-99m(Sn)pyridoxylideneaminate. In rats, Tc-99m(Sn)-N-pyridoxyl-5-methyltryptophan [Tc-99m(Sn)PHMT] showed rapid blood clearance, fast hepatobiliary transit, low urinary excretion, and no intestinal reabsorption. Over 90% of the dose arrived in the intestine through the liver at 30 min after i.v. administration, whereas only 2% of the dose escaped through the kidneys. In rabbits the gallbladder was clearly visualized within 5 min of injection and no renal or bladder images were noted on any scintiphotos. The BSP (sulfobromophthalein) intervention study revealed that the biliary excretion of Tc-99m(Sn)PHMT is much more resistant than that of Tc-99m(Sn) diethyl-IDA to the intervention of BSP and hence to serum bilirubin. Toxicity studies on PHMT and Sn-PHMT indicated a wide margin of safety for the proposed human dose.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1982 by the Society of Nuclear Medicine.